Abstract
Potent inhibitors of the human PDE IV enzyme are described. Substituted 8-arylquinoline analogs bearing nitrogen-linked side chain were identified as potent inhibitors based on the SAR described herein. The pharmacokinetic profile of the best analog and the in vivo efficacy in an ovalbumin-induced bronchoconstriction assay in conscious guinea pigs are reported.
MeSH terms
-
Animals
-
Biological Availability
-
Half-Life
-
Nitrogen / chemistry*
-
Phosphodiesterase Inhibitors / chemistry*
-
Phosphodiesterase Inhibitors / pharmacokinetics
-
Phosphodiesterase Inhibitors / pharmacology*
-
Quinolines / chemistry*
-
Quinolines / pharmacokinetics
-
Quinolines / pharmacology*
-
Rats
-
Saimiri
Substances
-
Phosphodiesterase Inhibitors
-
Quinolines
-
Nitrogen